As presented in Figure 7, candidate genes ACTR3, ARPC5, and HNRNPK were highly expressed in almost all types of lung cancer immune cells, while RAB13, PA2G4, and WDR12 were found to be less abundant in the majority of myeloid populations in lung cancer. This evidence concerns the gene ARPC5 and lung carcinoma.